Skip to content
2000
Volume 27, Issue 34
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Non-small cell lung cancer is usually diagnosed at the advanced stage of the disease. We have novel diagnostic tools. However, prevention is still the best way to deal with this disease. Patients receive different treatments with different adverse effects. Targeted treatment with tyrosine kinase inhibitors and immunotherapy have entered everyday clinical practice. The nutritional status of a patient plays a crucial role in the treatment of the patient. Cachexia is observed in most cancer patients, and it has been identified as an independent factor in the overall survival of the patient. The improvement of nutritional status and metabolism directly impacts the quality of life, daily living, and overall survival of a lung cancer patient. We conducted a search on PubMed and Scopus and identified relevant publications. In this review, we will focus on the nutritional status of NSCLC patients and how food supplements assist in the QoL based on published literature. Additional information from other cancer types will be included where necessary.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/1381612827999210111193133
2021-09-01
2025-04-10
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/1381612827999210111193133
Loading

  • Article Type:
    Review Article
Keyword(s): cancer; chemotherapy; immunotherapy; NSCLC; nutrition; tyrosine kinase inhibitors
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test